A Powerbook G4 is barely fast enough to run a large language model
A software developer has proven it is possible to run a modern LLM on old hardware like a 2005 PowerBook G4, albeit nowhere ...
Revenue Soars With 137% Year-On-Year Growth, Multiple Products Poised For Launch, Cansinobio's Growth Momentum Strong
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong ...
CU medical researchers lose federal grants to study vaccine hesitancy, Alzheimer’s
The National Institutes of Health are the world’s largest funder of medical research, distributing $35 billion in in grants ...
How Many Types Of Insects Are There In The World?
Curious Kids is a series for children of all ages. If you have a question you'd like an expert to answer, send it to ... .</ ...
Rats don’t run this city: Why Philly fields fewer rat complaints than New York City and D.C.
Compared to nearby cities, Philly seems to have a much lower rat population, or at least is home to vermin who are better at ...
Beware the coming Mac malware season
TechCrunch caught the Have I Been Pwned story that a consumer-grade spyware outfit called SpyX was breached last year. The 25 ...
Security Boulevard20h
The Illusion of Safety: BlackCloak’s DEP Security Framework Exposes the Devil’s Greatest Trick
BlackCloak released a watershed asset in executive and public persona cybersecurity: The Digital Executive Protection (DEP) Framework & Assessment Methodology - a comprehensive standard designed to ...
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Chikungunya cases have spiked substantially in La Réunion since early 2025, with 8,600 cases recorded and almost 3,000 new cases during the week of March 3 to 9, 2025 1. Similar to the 2005-2006 ...
Security Boulevard5d
How CASB security protects your school district
Many districts remain unaware of CASBs or their necessity despite relying on cloud applications. This guide explains how ...
Pharmabiz5d
Novartis announces positive data from phase III study of intrathecal onasemnogene abeparvovec in broad patient population with SMA
Novartis announces positive data from phase III study of intrathecal onasemnogene abeparvovec in broad patient population with SMA: Basel Friday, March 21, 2025, 11:00 Hrs [IST] N ...